# C4 Therapeutics, Inc.: Form 8-K, filed Oct 6, 2020

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: 8-K
- Filed: 2020-10-06
- Accepted by EDGAR: Oct 6, 2020, 16:46 ET
- Period: 2020-10-01
- Accession: 0001193125-20-264807
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000119312520264807/d17027d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000119312520264807/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000119312520264807/d17027d8k.htm

Filed Oct 6, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-264807. Last ingested by Listed: Nov 14, 2026, 19:39 ET. No prices; not investment advice.
